{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:39:00Z","timestamp":1761323940135},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,3,30]],"date-time":"2014-03-30T00:00:00Z","timestamp":1396137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s13277-014-1853-9","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T01:24:55Z","timestamp":1396056295000},"page":"6455-6465","source":"Crossref","is-referenced-by-count":16,"title":["Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival"],"prefix":"10.1007","volume":"35","author":[{"given":"Stamatios","family":"Theocharis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioly","family":"Kotta-Loizou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Giaginis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eougken","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Sastre-Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,30]]},"reference":[{"key":"1853_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02699050500284218","volume":"24","author":"S Yoon","year":"2006","unstructured":"Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006;24:21\u201344.","journal-title":"Growth Factors"},{"key":"1853_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1947601911407328","volume":"2","author":"I Wortzel","year":"2011","unstructured":"Wortzel I, Seger R. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer. 2011;2:195\u2013209.","journal-title":"Genes Cancer."},{"key":"1853_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/biof.52","volume":"35","author":"Z Yao","year":"2009","unstructured":"Yao Z, Seger R. The ERK signaling cascade\u2013views from different subcellular compartments. Biofactors. 2009;35:407\u201316.","journal-title":"Biofactors"},{"key":"1853_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","volume":"15","author":"K Lorenz","year":"2009","unstructured":"Lorenz K, Schmitt JP, Schmitteckert EM, Lohse MJ. A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy. Nat Med. 2009;15:75\u201383.","journal-title":"Nat Med"},{"key":"1853_CR5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10799893.2012.695798","volume":"32","author":"MA Chetram","year":"2012","unstructured":"Chetram MA, Hinton CV. PTEN regulation of ERK1\/2 signaling in cancer. J Recept Signal Transduct Res. 2012;32:190\u20135.","journal-title":"J Recept Signal Transduct Res"},{"key":"1853_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1015543713485","volume":"20","author":"B Nicholson","year":"2001","unstructured":"Nicholson B, Schaefer G, Theodorescu D. Angiogenesis in prostate cancer: biology and therapeutic opportunities. Cancer Metastasis Rev. 2001;20:297\u2013319.","journal-title":"Cancer Metastasis Rev"},{"key":"1853_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1853_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J. Targeting RAS, signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1853_CR9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","volume":"5","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock C, Karasarides M, Marais R. The RAF proteins take center stage. Nat Rev Mol Cell Biol. 2004;5:875\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1853_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.01.022","volume":"283","author":"C Montagut","year":"2009","unstructured":"Montagut C, Settleman J. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 2009;283:125\u201334.","journal-title":"Cancer Lett"},{"key":"1853_CR11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1248\/bpb.34.1781","volume":"34","author":"M Kohno","year":"2011","unstructured":"Kohno M, Tanimura S, Ozaki K. Targeting the extracellular signal-regulated kinase pathway in cancer therapy. Biol Pharm Bull. 2011;34:1781\u20134.","journal-title":"Biol Pharm Bull"},{"key":"1853_CR12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.oraloncology.2010.06.006","volume":"46","author":"IO Bello","year":"2010","unstructured":"Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol. 2010;46:630\u20135.","journal-title":"Oral Oncol"},{"key":"1853_CR13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 2007;26:645\u201362.","journal-title":"Cancer Metastasis Rev"},{"key":"1853_CR14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20\u201344 years. Cancer. 2005;103:1843\u20139.","journal-title":"Cancer"},{"key":"1853_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","volume":"29","author":"M Brandwein-Gensler","year":"2005","unstructured":"Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29:167\u201378.","journal-title":"Am J Surg Pathol"},{"key":"1853_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000227604","volume":"54","author":"S Shintani","year":"1997","unstructured":"Shintani S, Matsuura H, Hasegawa Y, Nakayama B, Fujimoto Y. The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue. Oncology. 1997;54:463\u20137.","journal-title":"Oncology"},{"key":"1853_CR17","volume-title":"World Health Organization classifications tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson JW, Reichert P, Sidransky D. World Health Organization classifications tumours. Pathology and genetics of head and neck tumours: Lyon, IARC Press; 2005."},{"key":"1853_CR18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/1097-0142(19950401)75:7<1649::AID-CNCR2820750715>3.0.CO;2-E","volume":"75","author":"J Klijanienko","year":"1995","unstructured":"Klijanienko J, el-Naggar AK, de Braud, et al. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer. 1995;75:1649\u201356.","journal-title":"Cancer"},{"key":"1853_CR19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hed.10094","volume":"24","author":"A Po Wing Yen","year":"2002","unstructured":"Po Wing Yen A, Lam KY, Lam LK, et al. Prognostic factors clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score and pathologic features. Head Neck. 2002;24:513\u201320.","journal-title":"Head Neck"},{"key":"1853_CR20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2559.2011.03947.x","volume":"59","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C, et al. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. Histopathology. 2011;59:514\u201325.","journal-title":"Histopathology"},{"key":"1853_CR21","doi-asserted-by":"crossref","unstructured":"Theocharis S, Klijanienko J, Giaginis C, Alexandrou P, Patsouris E, Sastre-Garau X. Ephrin Receptor (Eph) -A1, \u2212A2, \u2212A4 and -A7 Expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. Pathol Oncol Res. In press.","DOI":"10.1007\/s12253-013-9692-3"},{"key":"1853_CR22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0714.2008.00656.x","volume":"37","author":"TM S\u00f8land","year":"2008","unstructured":"S\u00f8land TM, Husvik C, Koppang HS, et al. A study of phosphorylated ERK1\/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. J Oral Pathol Med. 2008;37:535\u201342.","journal-title":"J Oral Pathol Med"},{"key":"1853_CR23","first-page":"473","volume":"27","author":"Z Yang","year":"2013","unstructured":"Yang Z, Guan B, Men T, Fujimoto J, Xu X. Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients. In Vivo. 2013;27:473\u201384.","journal-title":"In Vivo."},{"key":"1853_CR24","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1038\/sj.onc.1208626","volume":"24","author":"S Svensson","year":"2005","unstructured":"Svensson S, Jirstrom K, Ryden L, et al. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene. 2005;24:4370\u20139.","journal-title":"Oncogene"},{"key":"1853_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/1471-2407-10-458","volume":"10","author":"B Massidda","year":"2010","unstructured":"Massidda B, Sini M, Budroni M, et al. Molecular alterations in key-regulator genes among patients with T4 breast carcinoma. BMC Cancer. 2010;10:458.","journal-title":"BMC Cancer"},{"key":"1853_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-11-79","volume":"11","author":"L Ma","year":"2012","unstructured":"Ma L, Lan F, Zheng Z, et al. Epidermal growth factor (EGF) and interleukin (IL)-1beta synergistically promote ERK1\/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer. 2012;11:79.","journal-title":"Mol Cancer"},{"key":"1853_CR27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjc.6601644","volume":"90","author":"S Vicent","year":"2004","unstructured":"Vicent S, Lopez-Picazo JM, Toledo G, et al. ERK1\/2 is activated in non-small-cell lung cancer and associated with advanced tumors. Br J Cancer. 2004;90:1047\u201352.","journal-title":"Br J Cancer"},{"key":"1853_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjc.6604781","volume":"100","author":"MI Galleges Ruiz","year":"2009","unstructured":"Galleges Ruiz MI, Floor K, Steinberg SM, et al. Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients. Br J Cancer. 2009;100:145\u201352.","journal-title":"Br J Cancer"},{"key":"1853_CR29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13277-010-0131-8","volume":"32","author":"Y Shi","year":"2011","unstructured":"Shi Y, Chen L, Li J, et al. Prognostic and predictive values of pERK1\/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy. Tumour Biol. 2011;32:381\u201390.","journal-title":"Tumour Biol"},{"key":"1853_CR30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000329063","volume":"80","author":"A Atmaca","year":"2011","unstructured":"Atmaca A, Pauligk C, Steinmetz K, Altmannsberger HM, J\u00e4ger E, Al-Batran SE. Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology. 2011;80:130\u20134.","journal-title":"Oncology"},{"key":"1853_CR31","doi-asserted-by":"crossref","first-page":"e70311","DOI":"10.1371\/journal.pone.0070311","volume":"8","author":"ZY Luo","year":"2013","unstructured":"Luo ZY, Wang YY, Zhao ZS, Li B, Chen JF. The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer. PLoS One. 2013;8:e70311.","journal-title":"PLoS One"},{"key":"1853_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jhep.2007.08.018","volume":"48","author":"KJ Schmitz","year":"2008","unstructured":"Schmitz KJ, Wohlschlaeger J, Lang H, et al. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 2008;48:83\u201390.","journal-title":"J Hepatol"},{"key":"1853_CR33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MPA.0b013e318238379d","volume":"41","author":"A Handra-Luca","year":"2012","unstructured":"Handra-Luca A, Lesty C, Hammel P, et al. Biological and prognostic relevance of mitogen-activated protein kinases in pancreatic adenocarcinoma. Pancreas. 2012;41:416\u201321.","journal-title":"Pancreas"},{"key":"1853_CR34","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/cncr.24389","volume":"115","author":"L Campbell","year":"2009","unstructured":"Campbell L, Nuttall R, Griffiths D, Gumbleton M. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma. Cancer. 2009;115:3457\u201367.","journal-title":"Cancer"},{"key":"1853_CR35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1349-7006.2007.00445.x","volume":"98","author":"Y Mizumoto","year":"2007","unstructured":"Mizumoto Y, Kyo S, Mori N, et al. Activation of ERK1\/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis. Cancer Sci. 2007;98:652\u20138.","journal-title":"Cancer Sci"},{"key":"1853_CR36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00313020902885011","volume":"41","author":"M Karlou","year":"2009","unstructured":"Karlou M, Saetta AA, Korkolopoulou P, et al. Activation of extracellular regulated kinases (ERK1\/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations. Pathology. 2009;41:327\u201334.","journal-title":"Pathology"},{"key":"1853_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-006-0342-y","volume":"450","author":"KJ Schmitz","year":"2007","unstructured":"Schmitz KJ, Wohlschlaeger J, Alakus H, et al. Activation of extracellular regulated kinases (ERK1\/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations. Virchows Arch. 2007;450:151\u20139.","journal-title":"Virchows Arch"},{"key":"1853_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1477-7819-10-47","volume":"10","author":"G Levidou","year":"2012","unstructured":"Levidou G, Saetta AA, Gigelou F, et al. ERK\/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World J Surg Oncol. 2012;10:47.","journal-title":"World J Surg Oncol."},{"key":"1853_CR39","first-page":"5325","volume":"9","author":"K Jorgensen","year":"2003","unstructured":"Jorgensen K, Holm R, Maelandsmo GM, Florenes VA. Expression of activated extracellular signal-regulated kinases 1\/2 in malignant melanomas: relationship with clinical outcome. Clin Cancer Res. 2003;9:5325\u201331.","journal-title":"Clin Cancer Res"},{"key":"1853_CR40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1136\/jcp.2005.025957","volume":"58","author":"L Zhuang","year":"2005","unstructured":"Zhuang L, Lee CS, Scolyer RA, et al. Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. J Clin Pathol. 2005;58:1163\u20139.","journal-title":"J Clin Pathol"},{"key":"1853_CR41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/PAT.0b013e32835803bc","volume":"44","author":"KY Na","year":"2012","unstructured":"Na KY, Kim YW, Park YK. Mitogen-activated protein kinase pathway in osteosarcoma. Pathology. 2012;44:540\u20136.","journal-title":"Pathology"},{"key":"1853_CR42","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2006-05-021071","volume":"109","author":"C Gregorj","year":"2007","unstructured":"Gregorj C, Ricciardi MR, Petrucci MT, et al. ERK1\/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood. 2007;109:5473\u20136.","journal-title":"Blood"},{"key":"1853_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-9966-28-39","volume":"28","author":"V D'Angelo","year":"2009","unstructured":"D'Angelo V, Crisci S, Casale F, et al. High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases. J Exp Clin Cancer Res. 2009;28:39.","journal-title":"J Exp Clin Cancer Res"},{"key":"1853_CR44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.oraloncology.2005.11.002","volume":"42","author":"L Wang","year":"2006","unstructured":"Wang L, Liu T, Nishioka M, Aguirre RL, Win SS, Okada N. Activation of ERK1\/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol. 2006;42:625\u201331.","journal-title":"Oral Oncol"},{"key":"1853_CR45","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1242\/jcs.02505","volume":"118","author":"M Ebisuya","year":"2005","unstructured":"Ebisuya M, Kondoh K, Nishida E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci. 2005;118:2997\u20133002.","journal-title":"J Cell Sci"},{"key":"1853_CR46","first-page":"4433","volume":"2013","author":"K Kavitha","year":"1830","unstructured":"Kavitha K, Kowshik J, Kishore TK, Baba AB, Nagini S. Astaxanthin inhibits NF-\u03baB and Wnt\/\u03b2-catenin signaling pathways via inactivation of Erk\/MAPK and PI3K\/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim Biophys Acta. 1830;2013:4433\u201344.","journal-title":"Biochim Biophys Acta"},{"key":"1853_CR47","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4149\/neo_2013_052","volume":"60","author":"B Li","year":"2013","unstructured":"Li B, Lu L, Zhong M, et al. Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in oral squamous cell carcinoma cells. Neoplasma. 2013;60:406\u201312.","journal-title":"Neoplasma"},{"key":"1853_CR48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ptr.2989","volume":"24","author":"HK Shin","year":"2010","unstructured":"Shin HK, Kim J, Lee EJ, Kim SH. Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations. Phytother Res. 2010;24:577\u201382.","journal-title":"Phytother Res"},{"key":"1853_CR49","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tiv.2010.01.010","volume":"24","author":"IS Park","year":"2010","unstructured":"Park IS, Jo JR, Hong H, et al. Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1\/2 and AKT. Toxicol In Vitro. 2010;24:713\u201320.","journal-title":"Toxicol In Vitro."},{"key":"1853_CR50","first-page":"4789","volume":"23","author":"R Knecht","year":"2003","unstructured":"Knecht R, Peters S, Solbach C, Baghi M, Gst\u00f6ttner W, Hambek M. EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment. Anticancer Res. 2003;23:4789\u201395.","journal-title":"Anticancer Res"},{"key":"1853_CR51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/0008-5472.CAN-06-2162","volume":"67","author":"JH Lorch","year":"2007","unstructured":"Lorch JH, Thomas TO, Schmoll HJ. Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer. Cancer Res. 2007;67:727\u201334.","journal-title":"Cancer Res"},{"key":"1853_CR52","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2741\/3735","volume":"16","author":"L Masuelli","year":"2011","unstructured":"Masuelli L, Marzocchella L, Quaranta A, Palumbo C, Pompa G, Izzi V, et al. Apigenin induces apoptosis and impairs head and neck carcinomas EGFR\/ErbB2 signaling. Front Biosci (Landmark Ed). 2011;16:1060\u20138.","journal-title":"Front Biosci (Landmark Ed)."},{"key":"1853_CR53","doi-asserted-by":"crossref","first-page":"e38047","DOI":"10.1371\/journal.pone.0038047","volume":"7","author":"RK Wali","year":"2012","unstructured":"Wali RK, Kunte DP, De La Cruz M, Tiwari AK, Brasky J, Weber CR, et al. Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response. PLoS One. 2012;7:e38047.","journal-title":"PLoS One"},{"key":"1853_CR54","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291\u2013310.","journal-title":"Oncogene"},{"key":"1853_CR55","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-07-4790","volume":"14","author":"BB Friday","year":"2008","unstructured":"Friday BB, Adjei AA. Advances in targeting the Ras\/Raf\/MEK\/Erk mitogen activated protein kinase cascade with M EK inhibitors for cancer therapy. Clin Cancer Res. 2008;14:342\u20136.","journal-title":"Clin Cancer Res"},{"key":"1853_CR56","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-09-3064","volume":"16","author":"CA Pratilas","year":"2010","unstructured":"Pratilas CA, Solit DB. Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response. Clin Cancer Res. 2010;16:3329\u201334.","journal-title":"Clin Cancer Res"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1853-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-1853-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1853-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:39:13Z","timestamp":1648712353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-1853-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,30]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-1853-9","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,30]]}}}